End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 CNY | -1.73% |
|
-6.07% | -52.60% |
25/06 | Yahong Meditech to Trial Drug Against Amoebae Infection | MT |
17/06 | ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-52.60% | 41Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.65TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.62TCr | |
-20.90% | 1.54TCr | |
-46.14% | 1.52TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.35TCr |
- Stock Market
- Equities
- 688176 Stock
- News Jiangsu Yahong Meditech Co., Ltd.
- Yahong Meditech to Trial Drug Against Amoebae Infection